Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon
  • Photobucket

  • FDA Registered Contract Manufacturer

Relypsa (Santa Clara, CA) a clinical-stage developer of a therapeutic for hyperkalemia in congestive heart failure patients, closed a $70M Series B financing. Participants include 5AM Ventures, New Leaf Partners, Delphi Ventures and OrbiMed Advisors.

Relypsa (Santa Clara, CA) a clinical-stage developer of a therapeutic for hyperkalemia in congestive heart failure patients closed a $10M Series A financing, the final tranche of the $43M round. Participants include 5AM Ventures, New Leaf Partners, Sprout Group, Delphi Ventures, CMEA Ventures and Mediphase Venture Partners.

  

to top of page...